m40 and Disease Models, Animal
m40 has been researched along with Disease Models, Animal in 6 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Edwards, GL; Freeman, KG; Holmes, PV; Sciolino, NR; Smith, JM; Stranahan, AM; Weinshenker, D | 1 |
| Chen, A; Chen, Y; He, B; Li, M; Luo, Z; Song, L; Zhang, W; Zhang, Y | 1 |
| Mazarati, A; Medel-Matus, JS; Sankar, R; Shin, D | 1 |
| Barreto, SG; Bhandari, M; Carati, CJ; Kawamoto, M; Saccone, GT; Schloithe, AC; Thomas, AC; Toouli, J | 1 |
| Crawley, JN; McDonald, MP; Wenk, GL | 1 |
| Crawley, JN; McDonald, MP; Wenk, GL; Willard, LB | 1 |
Other Studies
6 other study(ies) available for m40 and Disease Models, Animal
| Article | Year |
|---|---|
Galanin mediates features of neural and behavioral stress resilience afforded by exercise.
Topics: Animals; Anxiety; Brain; Chromatography, High Pressure Liquid; Disease Models, Animal; Electroshock; Enzyme-Linked Immunosorbent Assay; Exploratory Behavior; Galanin; Infusions, Intraventricular; Male; Maze Learning; Microdialysis; Neurons; Peptide Fragments; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Silver Staining; Stress, Psychological | 2015 |
Effects of the Galanin Receptor Antagonist M40 on Cardiac Function and Remodeling in Rats with Heart Failure.
Topics: Animals; Cardiotonic Agents; Coloring Agents; Disease Models, Animal; Electrocardiography; Endomyocardial Fibrosis; Enzyme-Linked Immunosorbent Assay; Galanin; Heart Failure; Interleukin-6; Male; Myocardium; Natriuretic Peptide, Brain; Organ Size; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Galanin; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2015 |
Galanin contributes to monoaminergic dysfunction and to dependent neurobehavioral comorbidities of epilepsy.
Topics: Animals; Antidepressive Agents; Biogenic Monoamines; Depression; Disease Models, Animal; Drug Delivery Systems; Galactolipids; Galanin; Impulsive Behavior; Lithium Chloride; Locus Coeruleus; Male; Muscarinic Agonists; Peptide Fragments; Pilocarpine; Raphe Nuclei; Rats; Rats, Wistar; Serotonin; Status Epilepticus; Swimming | 2017 |
Galanin receptor antagonist m35 but not m40 or c7 ameliorates cerulein-induced acute pancreatitis in mice.
Topics: Animals; Bradykinin; Ceruletide; Complement C7; Disease Models, Animal; Drug Therapy, Combination; Galanin; Male; Mice; Necrosis; Pancreas; Pancreatitis, Acute Necrotizing; Peptide Fragments; Peroxidase; Receptors, Galanin | 2010 |
Analysis of galanin and the galanin antagonist M40 on delayed non-matching-to-position performance in rats lesioned with the cholinergic immunotoxin 192 IgG-saporin.
Topics: Alzheimer Disease; Animals; Antibodies, Monoclonal; Brain Mapping; Discrimination Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Galanin; Hippocampus; Immunotoxins; Male; Mental Recall; N-Glycosyl Hydrolases; Orientation; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Receptors, Galanin; Receptors, Gastrointestinal Hormone; Ribosome Inactivating Proteins, Type 1; Saporins | 1997 |
Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions.
Topics: Acetylcholine; Alzheimer Disease; Animals; Antibodies, Monoclonal; Behavior, Animal; Choice Behavior; Cholinergic Agents; Cholinergic Fibers; Cognition; Disease Models, Animal; Dose-Response Relationship, Drug; Galanin; Immunotoxins; Male; Memory; Muscarinic Agonists; N-Glycosyl Hydrolases; Peptide Fragments; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, Muscarinic; Ribosome Inactivating Proteins, Type 1; Saporins; Thiadiazoles | 1998 |